Jonathan David Schwartz, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 270,000 shares at $15.94 ($4.4M) on 2022-03-30, disclosed to the SEC on 2022-04-04.
Open-market sale of $4.4M RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.94 | 10,562 | $168K | 3.8% |
| 2 | $15.94 | 10,562 | $168K | 3.8% |
| 3 | $16.56 | 34,438 | $570K | 13.0% |
| 4 | $16.56 | 34,438 | $570K | 13.0% |
| 5 | $15.90 | 9,002 | $143K | 3.3% |
| 6 | $15.90 | 9,002 |
| $143K |
| 3.3% |
| 7 | $16.15 | 35,998 | $581K | 13.3% |
| 8 | $16.15 | 35,998 | $581K | 13.3% |
| 9 | $15.86 | 12,974 | $206K | 4.7% |
| 10 | $15.86 | 12,974 | $206K | 4.7% |
| 11 | $16.20 | 32,026 | $519K | 11.9% |
| 12 | $16.20 | 32,026 | $519K | 11.9% |
| Total | $16.21 avg | 270,000 | $4.4M | 100% |
| Filing → |
| RCKT | SELL | 2025-08-18 | $34K | — | Filing → |
| RCKT | SELL | 2025-05-22 | $5K | — | Filing → |
| RCKT | SELL | 2025-05-20 | $10K | — | Filing → |